Pharma industry has only 2 to 3 months stock

Hyderabad: Describing the situation in terms of raw material import from China as "grim," India Pharmaceutical Alliance (IPA) said the Indian Pharma Industry has enough stocks of active pharmaceutical ingredient (APIs) for two to three months only.

Speaking on the sidelines of BioAsia 2020, IPA Secretary General Sudarshan Jain said they were in touch with the Centre, seeking faster environmental clearances for some of the API manufacturing units so that dependence on China was reduced.

According to Jain, India imports Rs 17,000 crore worth of APIs from the Novel Coronavirus-hit nation.

"It is a very critical and serious situation. No one has got the full predictability of what is happening. We have inventories for two to three months," Jain said.